PRINCETON, August 5, 2021: Morgan Lewis partner David Glazer has been recognized on the list of Dealmakers by the New Jersey Law Journal as part of its New Jersey Legal Awards, which honor those who have “left an indelible mark on the legal community in New Jersey and beyond through their unwavering dedication to the profession.” David, who leads the firm’s life sciences transactions practice, is one of six honorees in the category, which recognizes transactional lawyers who achieved excellence in the last year.
David represents clients ranging from biotechnology startups to global Fortune 100 pharmaceutical companies. Working closely with clients to understand their businesses, David structures and negotiates deals to meet their objectives and find practical solutions to complex problems. David brings a background in drug and medical device development and commercialization, early-stage research and development of late-stage product deals, and issues related to the life sciences industry such as indication, field, and territory splitting.
David and the other honorees are set to be recognized at a gala scheduled for September.